The Second 'Tojong' Treatment Emerges! Clinical Trial Results Imminent!!

※ For those who missed the ‘COVID-19 treatment’ opportunity, don’t worry. Here comes another big chance.

※ Finally starting. GL PharmTech (204840) follow-up stock hits the upper limit on Tuesday. ※

▶▶ Straight to the ‘Upper Limit’ on Tuesday. Domestic treatment stock rally begins! Clinical trial results announcement imminent!! It’s going to explode strongly! [Apply now for ‘Second Treatment’ related stocks]

Celltrion’s self-developed COVID-19 treatment is about to receive approval from the Ministry of Food and Drug Safety! Meanwhile, competition to secure the second ‘native’ COVID-19 treatment is fierce! GC Green Cross is deriving clinical trial results for its plasma treatment, and Daewoong Pharmaceutical and Chong Kun Dang are also accelerating with a ‘drug repositioning’ approach! They plan to apply for conditional approval as soon as the final analysis of the Phase 2a clinical trial results is completed!

▶▶ Starting with the ‘Upper Limit’ on January 15! Domestic treatment stock rally begins! Clinical trial results announcement imminent!! Today only! ‘ㅇㅇㅇㅇ’ related ▶ Free trial application ◀

"At first, I was more worried." But now, I am very satisfied and using the service. Even when I applied for the 5-day free trial, I was given good stocks with high account returns, and after joining as a VIP member, I can receive even better service, so I am very satisfied. I truly think applying for this was lucky.

(VIP office worker Kim Junho, 51 years old)

Now think of this as the last chance. If you miss this opportunity, you have to give up.

Exactly on “January 19,” it will explode! Don’t miss out and regret it, just buy even with 100,000 KRW!

▶▶ “January 19 Upper Limit” offered only until today and then closed. [Receive ‘Treatment’ related stocks!] ▶Receive stocks◀

[AI recent upper limit hits]

*21.01.15 Korea Pharma (032300) Upper limit hit!

*21.01.13 Dongbang (004140) 3 consecutive upper limits hit!

*21.01.12 Dongbang (004140) 2 consecutive upper limits hit!

*21.01.11 Dongbang (004140) Upper limit hit!

*21.01.08 Lanix (317120) Upper limit hit!

*21.01.06 Samsung Pharmaceutical (001360) Upper limit hit!

*21.01.04 Green Cross LabCell (144510) Upper limit hit!